Aug 7 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2026 Jun 30, 2025 Jun 30, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.42 1.46 1.50
(-2.3 pct) (+8.1 pct) (+5.5 pct)
Operating 209 mln 249 mln 220 mln
(-15.9 pct) (+13.3 pct) (+4.8 pct)
Recurring 206 mln 240 mln 220 mln
(-14.2 pct) (-0.2 pct) (+6.4 pct)
Net
Net 200 mln 256 mln 170 mln
(-21.9 pct) (+5.4 pct) (-15.2 pct)
EPS 35.70 yen 43.67 yen 31.37 yen
Ann Div 18.00 yen 15.00 yen 18.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 18.00 yen 15.00 yen 18.00 yen
NOTE - Human Metabolome Technologies, Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T